A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects-Reference-Cited by-同舟云学术

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects

Published:2024-09-14 Issue:1 Volume:22 Page:
ISSN:1477-3155
Container-title:Journal of Nanobiotechnology
language:en
Short-container-title:J Nanobiotechnol

Author:

Xie Shenxia,Shi Wei,Duan Siliang,Huang Xianing,Liu Aiqun,Hou Xiaoqiong,Lin Xuandong,Zhong Dani,Sun Shuyang,Ding Ziqiang,Yang Xiaomei,Chen Xiaoyuan,Lu Xiaoling

Funder

Guangxi Natural Science Foundation Youth Fund Project of China

NUS School of Medicine Nanomedicine Translational Research Programme

the International (Regional) Cooperation and Exchange Program of National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12951-024-02781-1.pdf

Reference38 articles.

1. Leko V, Rosenberg SA. Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors. Cancer Cell. 2020;38:454–72.

2. van de Donk N, Zweegman S. T-cell-engaging bispecific antibodies in cancer. Lancet. 2023;402:142–58.

3. Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, et al. Tarlatamab for patients with previously treated small-cell Lung Cancer. N Engl J Med. 2023;389:2063–75.

4. Wörn A, Plückthun A. Stability engineering of antibody single-chain fv fragments. J Mol Biol. 2001;305:989–1010.

5. Enderle L, Shalaby KH, Gorelik M, Weiss A, Blazer LL, Paduch M, Cardarelli L, Kossiakoff A, Adams JJ, Sidhu SS. A T cell redirection platform for co-targeting dual antigens on solid tumors. MAbs. 2021;13:1933690.